Quest Diagnostics Profit Margin

The latest profit margin for DGX is 9.19% as of June 2026. That compares with 12.96% in the prior-year period — down 29.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Quest Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, DGX's profit margin moved from 12.96% to 9.19% — a 29.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Quest Diagnostics's valuation or profitability profile.

Against Healthcare companies, DGX currently prints 9.19% for profit margin, while the sector average sits near 15.58%. That is roughly 41.0% below the sector mean. Large gaps often invite a closer look at Quest Diagnostics's growth, margins, and balance sheet.

Profit Margin shows how effectively Quest Diagnostics converts resources into returns. At 9.19%, DGX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 12.96% in the prior-year period — down 29.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DGX's profit margin (9.19%), review year-over-year change from 12.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.